Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Stocks or Bonds – The Eternal Debate!: Bank of America Corp (BAC), Pfizer Inc. (PFE)

Page 1 of 2

One of the aspects that makes investing so interesting is the enormous impact psychology has on results (and profits) people achieve (or don’t).  What makes this so fascinating is there is an absolute plethora of information and research out there available for investors to utilize to educate themselves, yet so few do.

One such instance where the effect of psychology has impeded investor returns in the eternal battle of stocks vs. bonds. In 2012 stocks, at least according the press of popular opinion had nothing but bearish head winds blow against them. There were debt ceiling issues, the threat of credit rating downgrades, a slowing economy, double dip recession, the list was endless.

Bank of America Corp (NYSE:BAC)

Equally, bonds were supported (according to the media) by favorable tail winds and the grossly over used ‘safety of Treasuries’ mantra.

Yet for all the issues stocks has going against them, they actually outperformed bonds. Below is the relative graph of stocks as measured by the ETF SPY relative to Bonds as measured by the ETF TLT bond fund.

For the calendar year of 2012, TLT returned just 1.47%. I guess a return to be happy with if you believed deflation was going scourge the markets and collapse the prices of assets the world over. SPY however returned a respectable 11.69%.

Using SPY and TLT as proxies, stocks outperformed bonds on an absolute basis by some 10%. On a relative basis stocks were leaps and bounds ahead of bonds.

What is the lesson we can take away from this?

Be wary of blindly following the crowd and the popular opinion. Just because there a multitude of people and press publications espousing reasons for why a market will / should do something does not mean it necessarily will. In fact the stronger the consensus, the more likely that the exact opposite will happen!

Think about it for a minute. If everyone is bearish on stocks then who is left to sell? By definition if everyone (in a generalized sense) is bearish then they will have sold their stocks. So if they have sold out of stocks, who is left to sell and drive the price further down? The answer? Very few. Because of this the path of least resistance is up.

At the start of 2012 very few people would have predicted much less been willing to invest in the view that SPY would return nearly 12% for the year and dramatically outperform bonds. Yet this is exactly what happened.

Looking forward I pose the question, ‘is this bullish run coming to an end or is it just getting going?’ My guess – it still has a significant way to run and hence there is a good deal more upside in stocks. When the press of popular opinion is singing the praises of the stock market and focusing on all the great tail winds then I will be thinking this Bull Run is on its last legs. Until then I am backing equities

There are number of big cap stocks I like that when bundled together give investors a good, broad diverse exposure to the overall market. Stocks such as Bank of America Corp (NYSE:BAC) – in 2012 returned 100% (hmmm… bet not many people realized that!) Even with this retirement crunching return, Bank of America Corp (NYSE:BAC) is only trading at a Forward PE of 9.3, with a PEG ratio of just 0.65. Whilst Bank of America’s dividend yield is small at just 0.3%, it is useful to keep in mind the payout ratio is a very conservative 16%.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!